Tyers Asset Management’s Edwards Lifesciences EW Stock Holding History

Tyers Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$2.58M	Buy	35,196 +4,620	+15%	+$325K	0.09%	197
2019 Q2	$1.88M	Buy	30,576 +4,620	+18%	+$279K	0.06%	236
2019 Q1	$1.66M	Buy	25,956 +3,360	+15%	+$192K	0.06%	246
2018 Q4	$1.15M	Buy	22,596 +2,352	+12%	+$119K	0.05%	261
2018 Q3	$1.18M	Sell	20,244 -252	-1%	-$12.3K	0.04%	274
2018 Q2	$995K	Buy	20,496 +1,176	+6%	+$54.9K	0.03%	294
2018 Q1	$899K	Sell	19,320 -1,680	-8%	-$73K	0.03%	289
2017 Q4	$789K	Buy	21,000 +4,872	+30%	+$179K	0.03%	323
2017 Q3	$588K	Sell	16,128 -8,652	-35%	-$330K	0.02%	363
2017 Q2	$977K	Sell	24,780 -13,188	-35%	-$481K	0.04%	283
2017 Q1	$1.19M	Sell	37,968 -76,692	-67%	-$2.4M	0.05%	254
2016 Q4	$3.58M	Buy	+114,660	New	+$3.72M	0.15%	129

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Tyers Asset Management's EW Position: Q3 2019 in Review

Tyers Asset Management increased its Edwards Lifesciences (EW) stake by 15% in Q3 2019, buying an estimated $325K and bringing the position to 35,196 shares worth $2.58M. The position accounts for 0.09% of the portfolio, ranked #197.

Tyers Asset Management first reported a position in EW in Q4 2016 and has held it in 12 quarters since. The position peaked at $3.58M in Q4 2016. 965 funds tracked by Wall St. Rank hold EW as of Q3 2019.

Tyers Asset Management held 35,196 shares of Edwards Lifesciences worth $2.58M as of Q3 2019.
Tyers Asset Management bought 4,620 Edwards Lifesciences shares in Q3 2019, an estimated $325K.
Edwards Lifesciences made up 0.09% of Tyers Asset Management's portfolio in Q3 2019, its #197 holding.
Tyers Asset Management first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 12 quarters since.
Tyers Asset Management's Edwards Lifesciences position peaked at $3.58M in Q4 2016.
965 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.